These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
371 related articles for article (PubMed ID: 11774737)
1. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics. Kobayashi H; Takemura Y; Miyachi H Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737 [TBL] [Abstract][Full Text] [Related]
2. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites. Kobayashi H; Takemura Y; Wang FS; Oka T; Ohnuma T Int J Cancer; 1999 Jun; 81(6):944-50. PubMed ID: 10362143 [TBL] [Abstract][Full Text] [Related]
3. Reversal of multidrug resistance by a liposome-MDR1 ribozyme complex. Masuda Y; Kobayashi H; Holland JF; Ohnuma T Cancer Chemother Pharmacol; 1998; 42(1):9-16. PubMed ID: 9619752 [TBL] [Abstract][Full Text] [Related]
4. Overcoming multi-drug resistance by anti-MDR1 ribozyme. Wang H; Chen XP; Qiu FZ World J Gastroenterol; 2003 Jul; 9(7):1444-9. PubMed ID: 12854138 [TBL] [Abstract][Full Text] [Related]
5. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes. Kaszubiak A; Holm PS; Lage H Int J Oncol; 2007 Aug; 31(2):419-30. PubMed ID: 17611700 [TBL] [Abstract][Full Text] [Related]
6. Retrovirus-mediated transfer of anti-MDR1 ribozymes fully restores chemosensitivity of P-glycoprotein-expressing human lymphoma cells. Wang FS; Kobayashi H; Liang KW; Holland JF; Ohnuma T Hum Gene Ther; 1999 May; 10(7):1185-95. PubMed ID: 10340550 [TBL] [Abstract][Full Text] [Related]
7. [Overcoming multi-drug resistance using anti-MDR1 ribozymes]. Wang H; Chen XP; Qiu FZ Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(7):424-7. PubMed ID: 15144672 [TBL] [Abstract][Full Text] [Related]
8. Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme. Kobayashi H; Dorai T; Holland JF; Ohnuma T Cancer Res; 1994 Mar; 54(5):1271-5. PubMed ID: 8118816 [TBL] [Abstract][Full Text] [Related]
9. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference. Stege A; Priebsch A; Nieth C; Lage H Cancer Gene Ther; 2004 Nov; 11(11):699-706. PubMed ID: 15375376 [TBL] [Abstract][Full Text] [Related]
10. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA. Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833 [TBL] [Abstract][Full Text] [Related]
11. Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists. Fu J; Chen Z; Cen J; Ruan C Chin Med J (Engl); 2000 Mar; 113(3):228-31. PubMed ID: 11775252 [TBL] [Abstract][Full Text] [Related]
12. Retroviral-mediated transfer and functional expression of multidrug resistance gene in human placenta mesenchymal stem cells. Han LY; Ye MZ; Li YP; Wang BW; Wang Q; Zhao SH; Li HL Chin Med J (Engl); 2008 May; 121(9):800-5. PubMed ID: 18701045 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of RNA helicase A by DNA-dependent protein kinase is indispensable for expression of the MDR1 gene product P-glycoprotein in multidrug-resistant human leukemia cells. Zhong X; Safa AR Biochemistry; 2007 May; 46(19):5766-75. PubMed ID: 17441731 [TBL] [Abstract][Full Text] [Related]
14. Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti-MDR1 ribozymes. Huesker M; Folmer Y; Schneider M; Fulda C; Blum HE; Hafkemeyer P Hepatology; 2002 Oct; 36(4 Pt 1):874-84. PubMed ID: 12297834 [TBL] [Abstract][Full Text] [Related]
15. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells. Molnar J; Mucsi I; Nacsa J; Hevér A; Gyémánt N; Ugocsai K; Hegyes P; Kiessig S; Gaal D; Lage H; Varga A Anticancer Res; 2004; 24(2B):865-71. PubMed ID: 15161039 [TBL] [Abstract][Full Text] [Related]
16. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB. He Y; Zhang J; Zhang J; Yuan Y Chin Med J (Engl); 2000 Sep; 113(9):848-51. PubMed ID: 11776085 [TBL] [Abstract][Full Text] [Related]
17. Reversal of drug resistance using hammerhead ribozymes against multidrug resistance-associated protein and multidrug resistance 1 gene. Nagata J; Kijima H; Hatanaka H; Asai S; Miyachi H; Abe Y; Yamazaki H; Nakamura M; Watanabe N; Mine T; Kondo T; Scanlon KJ; Ueyama Y Int J Oncol; 2002 Nov; 21(5):1021-6. PubMed ID: 12370750 [TBL] [Abstract][Full Text] [Related]
18. Reversal of MDR1 gene-dependent multidrug resistance using short hairpin RNA expression vectors. Gan HZ; Zhang GZ; Zhao JS; Zhang FC; Bu LS; Yang SJ; Piao SL; Du ZW; Gao S; Zheng DM Chin Med J (Engl); 2005 Jun; 118(11):893-902. PubMed ID: 15978189 [TBL] [Abstract][Full Text] [Related]
19. [Efficient expression of multidrug resistance gene mdr1 in retroviral vector under control of an internal ribosome entry site]. Fu J; Chen Z; Wang W Zhonghua Xue Ye Xue Za Zhi; 1998 Dec; 19(12):619-22. PubMed ID: 11263327 [TBL] [Abstract][Full Text] [Related]
20. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1. Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]